Canada markets closed

Adamas Pharmaceuticals, Inc. (ADMS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.220.00 (0.00%)
At close: 04:00PM EST
Currency in USD

Valuation Measures

Market Cap (intraday) 5376.37M
Enterprise Value 3427.41M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.61
Price/Book (mrq)N/A
Enterprise Value/Revenue 34.85
Enterprise Value/EBITDA 7-10.86

Trading Information

Stock Price History

Beta (5Y Monthly) 2.82
52-Week Change 372.33%
S&P500 52-Week Change 324.47%
52 Week High 39.15
52 Week Low 34.02
50-Day Moving Average 37.00
200-Day Moving Average 35.55

Share Statistics

Avg Vol (3 month) 31.32M
Avg Vol (10 day) 3964.73k
Shares Outstanding 545.79M
Implied Shares Outstanding 6N/A
Float 829.69M
% Held by Insiders 10.71%
% Held by Institutions 179.35%
Shares Short (Nov. 14, 2021) 4477.29k
Short Ratio (Nov. 14, 2021) 40.42
Short % of Float (Nov. 14, 2021) 41.17%
Short % of Shares Outstanding (Nov. 14, 2021) 41.04%
Shares Short (prior month Oct. 14, 2021) 41.6M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin -71.11%
Operating Margin (ttm)-38.66%

Management Effectiveness

Return on Assets (ttm)-15.40%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)88.19M
Revenue Per Share (ttm)2.28
Quarterly Revenue Growth (yoy)28.40%
Gross Profit (ttm)72.42M
EBITDA -33.58M
Net Income Avi to Common (ttm)-62.71M
Diluted EPS (ttm)-1.62
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)83.1M
Total Cash Per Share (mrq)1.82
Total Debt (mrq)136.26M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.53
Book Value Per Share (mrq)-0.47

Cash Flow Statement

Operating Cash Flow (ttm)-46.81M
Levered Free Cash Flow (ttm)-17.34M